When faced, for example, with the decision of whether or not to let a seriously ill or irreversible patient succumb voluntarily in terminal situations, we might avoid making the decision now, arguing for the possibility — maybe next week — that
a new cure for the patient's condition will be discovered.
Not exact matches
While the
new mid-stage study results from DNDi were impressive (they showed
cure rates of 96 % to 97 % even
for the sickest
patients and those with liver scarring), more late - stage trials will be necessary before the drug is available on a large scale in the developing world.
In listening to our terminally ill
patients, we were always impressed that even the most accepting, the most realistic
patients left the possibility open
for some
cure,
for the discovery of a
new drug or the «last minute success in a research project.»
The Bill - which was passed by the House of Lords - would have allowed doctors to test cutting edge
new treatments on
patients to help find
cures for cancer and other serious illnesses.
«In addition to creating
new beta cells, another issue that needs to be addressed to achieve a
cure for type 1 diabetes is that any
new beta cells will be attacked by the autoimmune response present in every
patient with type 1 diabetes.
A
new drug is offering dramatic
cure rates
for hepatitis C
patients with two subtypes of the infection — genotype 2 and 3, say a team of scientists led by Weill Cornell Medical College researchers.
An affordable hepatitis C combination treatment including the
new drug candidate ravidasvir has been shown to be safe and effective, with extremely high
cure rates
for patients, including hard - to - treat cases, according to interim results from the Phase II / III STORM - C - 1 trial presented by the non-profit research and development organisation Drugs
for Neglected Diseases initiative (DNDi) at the International Liver Conference in Paris.
«We're at a pivotal point where we're building upon what we've learned in the PLAT - 02 trial and opening
new trials, like PLAT - 04, with the goal of improving this therapy to the point that it becomes a long - term
cure for all of our leukemia
patients,» said Dr. Corinne Summers, an oncologist at Seattle Children's and the lead investigator of the PLAT - 04 trial.
It is worthwhile to give
patients expensive
new drugs that can
cure their hepatitis C much earlier than some insurers are now willing to pay
for them, according to a UC San Francisco study that models the effects of treating the disease early versus late in its development.
Hopefully, this
new knowledge will help to find a future
cure for patients who suffer such a devastating disease as LCA.»
Dr. Srivastava has co-founded a biotechnology company to help find
new cures for many human diseases and one of the developmental genes whose role he discovered, Thymosin β4, is currently in clinical trials
for patients suffering ischemic damage to the heart.
«Working closely alongside the drug development teams at Merck offers an outstanding opportunity to create
new benchmarks
for the R&D process, with the ultimate goal of optimizing drug candidates earlier by testing them in Organ - Chips that mirror what happens in the
patients whom the medicines are designed to treat and
cure,» said Geraldine A. Hamilton, Ph.D., President and Chief Scientific Officer of Emulate.
To deliver a functional
cure for all
patients with type 1 diabetes and an important
new therapy
for patients with type 2 disease that require insulin to maintain control, ViaCyte is developing products with numerous advantages including a virtually unlimited supply of cells manufactured under quality - controlled conditions, and a potentially safer and more optimal route of administration.
Today, more than half of the medulloblastoma
patients can be
cured, but there is a need
for new treatments.
And presumably you would see the disease in a dish, and that might allow you to actually look
for medicines or drugs that you could treat the dish and
cure the disease in a dish, and that might lead to
new therapies
for those
patients.
Armed with knowledge of which mistakes in genes are driving which cancers, doctors and scientists will be able to maximise the chances of
cure for each
patient by picking the best treatments and by developing
new and more targeted treatments
for people with oesophageal and prostate cancers in the future.
Where the money goes: It supports research that focuses on discovering
new treatments, giving
patients the right medicines, and assessing and minimizing risks in the hope of finding a
cure and a method of prevention
for breast cancer.
An inexplicably gifted human survivor with the ability to speak the
new mutant language leads a hunt
for Patient Zero and hope
for a
cure.»
New York About Blog The Carcinoid Cancer Foundation looks back on the highlights of previous years and to a future that they hope will bring greater awareness of carcinoid and neuroendocrine cancers, earlier diagnosis for patients, new treatment options, and continued research that will lead to a cure for these rare diseas
New York About Blog The Carcinoid Cancer Foundation looks back on the highlights of previous years and to a future that they hope will bring greater awareness of carcinoid and neuroendocrine cancers, earlier diagnosis
for patients,
new treatment options, and continued research that will lead to a cure for these rare diseas
new treatment options, and continued research that will lead to a
cure for these rare diseases.